I think you're missing a few very important qualifications for listing on the NYSE. If it were only those two, a R/S would qualify most OTC trip zero stinkers.
The uplisting question keeps coming up. There is a major barrier to doing so other than the normal $4.00 SP, reporting standards and whatnot, which are not easy requirements by themselves. If a company has direct contact with MJ and is operating on US soil, they will not be eligible to uplist until federal laws change. This is not in question. And I believe they do own stakes in several dispensaries. So that's a no go unless they only merge in the companies that don't touch MJ into the new corporation. Maybe that's their plan - just the banking stuff going public and the investment fund remaining private. In fact, the more I think about it, the more likely I think that is. Their status as a holding company may be a loophole, but I highly doubt it. There are other cannabis holding companies and none have uplisted; Curaleaf Holdings, for example, was a reverse merger on OTC and remain there.
All that being said, the laws WILL change sooner rather than later. The SAFE Act may allow it and that could happen next year. Perhaps by the time they would be prepared to uplist, it may be allowable. In the meantime, there's nothing holding them from being a powerhouse on the OTC.
Both exchanges prohibit listings from any company that breaks federal law in the jurisdiction they operate in. This is probably the best explanation I've seen. It's a lawyer's opinion:
"In November of 2011, the SEC approved new NASDAQ, NYSE, and AMEX rules that impose more stringent listing requirements for companies that become public through a Reverse Merger. These rules prohibit a Reverse Merger company from applying to list until it has completed a one-year “seasoning period” by trading in the U.S. over-the-counter market or on another regulated U.S. or foreign exchange following the Reverse Merger, and filed all required reports with the Commission, including audited financial statements. The company must also maintain a minimum share price of $2.00 to $4.00 for at least 30 of the 60 trading days, immediately prior to its listing application." https://www.securitieslawyer101.com/reverse-mergers/